Market Place
Sourcing Support
Biovitrum`s Biologic Kineret (Anakinra) Receives Suppl Approval in US
19 Sep 2024 //
FDA
U.S. Food and Drug Administration Issues Emergency Use Authorization for KINERET
10 Nov 2022 //
GLOBENEWSWIRE
FDA signs off on Sobi`s Kineret for patients with pneumonia who are on oxygen
10 Nov 2022 //
FIERCEPHARMA
EMA starts evaluating the use of Kineret in adult COVID-19 patients
19 Jul 2021 //
EMA
NICE recommends Sobi’s Kineret for first-line use in Still’s disease
01 Apr 2021 //
PHARMATIMES
NICE Issues Positive Recommendation for Use of Kineret to Treat Still’s Disease
31 Mar 2021 //
PHARMTECH
Kineret® (anakinra) approved in Russia for the treatment of CAPS
16 Feb 2021 //
PRNEWSWIRE
FDA Approves KINERET® for the Treatment of Deficiency of IL-1 Receptor
22 Dec 2020 //
GLOBENEWSWIRE
FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1
22 Dec 2020 //
GLOBENEWSWIRE
Biovitrum`s Kineret (Anakinra) Receives Supplemental Approval in US
22 Dec 2020 //
FDA
Sobi launches Kineret for AOSD, SJIA
17 Jul 2018 //
PHARMA TIMES
Could an old RA drug make CAR-T treatments safer?
07 Jun 2018 //
FIERCE BIOTECH
EMA’s CHMP Recommends Five New Medicines for Approval
26 Feb 2018 //
RAPS
New treatment option for rare inflammatory disease
22 Feb 2018 //
EMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.